The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Explore linked clinical trials.11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial | Capecitabine; Local Advanced Rectal Cancer; Oxaliplatin; PCSK9 Inhibitor; PD-1 Inhibitor; RCT; Radiotherapy | Not yet recruiting | Phase 3 | 2026-07-07 | NCT07686796 | |
| Electro-Acupuncture in Lung cancER : EALER Study | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2026-06-24 | NCT07337096 | |
| Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study | Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Recruiting | Not stated | 2026-04-29 | NCT07556224 | |
| Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System | Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Recruiting | Not stated | 2026-04-09 | NCT07509775 | |
| Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2025-12-17 | NCT06461338 | |
| EFG vs IVIG in TAMG | Efgartigimod; Intravenous Immunoglobulin; Myasthenia Gravis Associated With Thymoma | Not yet recruiting | Phase 3 | 2025-11-17 | NCT07231523 | |
| Evidence-Based Evaluation of Classic Herb Pair (Chuanxiong Rhizoma and Salviae Miltiorrhizae) for Preventing Recurrence of Diabetic Lower Extremity Arterial Disease | Diabetic Lower Extremity Arterial Disease | Not yet recruiting | Early phase 1 | 2025-08-24 | NCT07139639 | |
| Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients | Insulin Resistance, Nutritional and Metabolic Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, nervous system disorder, vascular disorder | Enrolling by invitation | Phase 3 | 2025-06-13 | NCT06908473 | |
| The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma | Peritoneal Carcinoma Metastatic | Recruiting | Phase 1 | 2024-12-20 | NCT06743867 | |
| Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 3 | 2024-08-27 | NCT06041477 | |
| A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy | Advanced NSCLC | Not yet recruiting | Phase 4 | 2024-04-10 | NCT06356675 |